ScholarLens Back to search
2003•Unpublished venueRequires access

Clinical Efficacy of Piperacillin/Tazobactam Used to Treat Ventilator-associated Pneumonia

Dai Jian

Open publisher page 0 citations

Abstract

OBJECTIVE To evaluate the clinical efficacy and safety in treating ventilator associated pneumonia with piperacillin/tazobactam. METHODS Thirty three patients with ventilator associated pneumonia were treated with piperacillin/tazobactam 4.5 g, iv drip q8h q12h for 7 14 d. RESULTS The total effective rate was 84.85%, the rate of bacteria clearance was 88.23%, side effect was less 3.03%. CONCLUSIONS Piperacillin/tazobactam appears to be an excellent agent for treatment of ventilator associated pneumonia.

About this research paper

What this paper is about

OBJECTIVE To evaluate the clinical efficacy and safety in treating ventilator associated pneumonia with piperacillin/tazobactam. METHODS Thirty three patients with ventilator associated pneumonia were treated with piperacillin/tazobactam 4.5 g, iv drip q8h q12h for 7 14 d. RESULTS The total effective rate was 84.85%, the rate of bacteria clearance was 88.23%, side effect was less 3.03%. CONCLUSIONS Piperacillin/tazobactam appears to be an excellent agent for treatment of ventilator associated pneumonia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To evaluate the clinical efficacy and safety in treating ventilator associated pneumonia with piperacillin/tazobactam. METHODS Thirty three patients with ventilator associated pneumonia were treated with piperacillin/tazobactam 4.5 g, iv drip q8h q12h for 7 14 d. RESULTS The total effective rate was 84.85%, the rate of bacteria clearance was 88.23%, side effect was less 3.03%. CONCLUSIONS Piperacillin/tazobactam appears to be an excellent agent for treatment of ventilator associated pneumonia.

Key concepts: Piperacillin/tazobactam, Piperacillin, Tazobactam, Medicine, Ventilator-associated pneumonia, Pneumonia, Clinical efficacy, Intensive care medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy of Piperacillin/Tazobactam Used to Treat Ventilator-associated Pneumonia — Research Paper | ScholarLens